International SOS Calls for Innovation in Crisis Management
New Comprehensive Global Crisis Management White Paper Leads the Way to Transform Crises into Catalysts for...
Manitoba Bioscience Group Applauds Government Support for Research
Bioscience Association Manitoba (BAM) welcomes the Manitoba government’s latest announcement to launch a Clinical Trials...
Dizal’s ZEGFROVY® Gets FDA Accelerated Approval for NSCLC Treatment
Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer...
Soligenix: Synthetic Hypericin Successfully Made at Sterling Pharma
Active Ingredient Manufacturing Transfer to the U.S. Complete Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company),...
Revolution, Summit to Test RAS(ON) Drugs with Ivonescimab
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients...
Nitinotes Gets FDA IDE Approval to Start U.S. Trial of EndoZip™ System
Advancing Minimally Invasive Obesity Treatment with Automated Suturing Technology Nitinotes, developer of the EndoZip™ System,...